Angioplasty Balloons Market (2026 - 2035)

ID: MRFR/HC/8136-HCR 200 Pages Rahul Gotadki Last Updated: November 16, 2026
Angioplasty Balloons Market Research Report By Product Type (Normal Balloons, Cutting Balloons, Scoring Balloons, Drug-Eluting Balloons), By Application (Coronary Angioplasty, Peripheral Angioplasty), By End User (Hospitals, Ambulatory Surgical Centers, Others) and By Region (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Growth Outlook & Industry Forecast 2026 To 2035
Angioplasty Balloons Market
Market Size
Forecast Period2026-2035
CAGR (2026-2035)3.82%
2025 Market SizeUSD 3.01 Billion
2035 Market SizeUSD 4.36 Billion
Key Players
Boston Scientific Corporation
Medtronic plc
Abbott Laboratories
B. Braun Melsungen AG
Terumo Corporation
Cardinal Health
Opportunities
  • Below-the-Knee and Long-Lesion Peripheral Therapy
  • Local Manufacturing in Emerging Markets
  • Bundled Contracts and Procedure Data Services
  1. 1 Market Summary | |
  2. 2 Key Report Takeaways | |
    1. 2.1 By Product Type | |
    2. 2.2 By Application | |
    3. 2.3 By End User | |
    4. 2.4 By Region | |
  3. 3 Market Size and Forecast (2021–2035) | |
  4. 4 Driver Impact Analysis | |
    1. 4.1 Rising Coronary and Peripheral Artery Disease Burden | |
    2. 4.2 Coronary Drug-Coated Balloon Approvals | |
    3. 4.3 Site-of-Care Shift to Ambulatory Surgical Centers | |
    4. 4.4 Growth in Calcified Lesion Treatment | |
    5. 4.5 Insurance-Led Procedure Growth in Asia-Pacific | |
    6. 4.6 Regulatory Clarity on Paclitaxel Safety | |
  5. 5 Restraints Impact Analysis | |
    1. 5.1 Volume-Based Procurement and Price Controls | |
    2. 5.2 EU MDR Certification Costs | |
    3. 5.3 Competition from Alternative Therapies | |
    4. 5.4 Limited Reimbursement in Emerging Markets | |
    5. 5.5 Shortage of Trained Interventional Operators | |
  6. 6 Opportunities | |
    1. 6.1 Below-the-Knee and Long-Lesion Peripheral Therapy | |
    2. 6.2 Local Manufacturing in Emerging Markets | |
    3. 6.3 Bundled Contracts and Procedure Data Services | |
    4. 6.4 Sirolimus-Coated Balloons | |
  7. 7 Regional Market Share and Country-Level Analysis | |
    1. 7.1 North America | | |
      1. 7.1.1 US | | |
      2. 7.1.2 Canada | | |
      3. 7.1.3 Mexico | |
    2. 7.2 Europe | | |
      1. 7.2.1 Germany | | |
      2. 7.2.2 UK | | |
      3. 7.2.3 France | | |
      4. 7.2.4 Italy | | |
      5. 7.2.5 Spain | | |
      6. 7.2.6 Nordic Countries | | |
      7. 7.2.7 Russia | | |
      8. 7.2.8 Rest of Europe | |
    3. 7.3 Asia-Pacific | | |
      1. 7.3.1 China | | |
      2. 7.3.2 India | | |
      3. 7.3.3 Japan | | |
      4. 7.3.4 South Korea | | |
      5. 7.3.5 ASEAN | | |
      6. 7.3.6 Rest of Asia-Pacific | |
    4. 7.4 South America | | |
      1. 7.4.1 Brazil | | |
      2. 7.4.2 Argentina | | |
      3. 7.4.3 Rest of South America | |
    5. 7.5 Middle East & Africa | | |
      1. 7.5.1 Saudi Arabia | | |
      2. 7.5.2 UAE | | |
      3. 7.5.3 South Africa | | |
      4. 7.5.4 Egypt | | |
      5. 7.5.5 Rest of MEA | |
  8. 8 Future Outlook (2026–2035) | |
    1. 8.1 Imaging- and AI-Guided Balloon Selection | |
    2. 8.2 The Leave-Nothing-Behind Strategy | |
    3. 8.3 Ageing Populations and Procedure Demand | |
    4. 8.4 Outpatient Care and Procurement Discipline | |
  9. 9 Segmentation Analysis | |
    1. 9.1 By Product Type | | |
      1. 9.1.1 Normal Balloons | | |
      2. 9.1.2 Cutting Balloons | | |
      3. 9.1.3 Scoring Balloons | | |
      4. 9.1.4 Drug-Eluting Balloons | |
    2. 9.2 By Application | | |
      1. 9.2.1 Coronary Angioplasty | | |
      2. 9.2.2 Peripheral Angioplasty | |
    3. 9.3 By End User | | |
      1. 9.3.1 Hospitals | | |
      2. 9.3.2 Ambulatory Surgical Centers | | |
      3. 9.3.3 Others | |
  10. 10 Competitive Landscape | |
    1. 10.1 Competitive Benchmarking | |
    2. 10.2 Company Profiles | | |
      1. 10.2.1 Boston Scientific Corporation | | |
      2. 10.2.2 Medtronic plc | | |
      3. 10.2.3 Abbott Laboratories | | |
      4. 10.2.4 B. Braun Melsungen AG | | |
      5. 10.2.5 Terumo Corporation | | |
      6. 10.2.6 Cardinal Health (Cordis) | | |
      7. 10.2.7 Becton, Dickinson and Company | | |
      8. 10.2.8 Johnson & Johnson MedTech (Shockwave) | | |
      9. 10.2.9 Biotronik SE & Co. KG | | |
      10. 10.2.10 Koninklijke Philips N.V. | | |
      11. 10.2.11 Teleflex Incorporated | |
  11. 11 Recent News & Developments | |
  12. 12 Report Scope and Methodology | |
  13. 13 Detailed Sources and Citations | |
  14. 14 Frequently Asked Questions (FAQs) | | LIST OF TABLES | |
  15. TABLE 1 Global Market Snapshot, 2025–2035 | |
  16. TABLE 2 Global Market Size and Forecast, by Revenue (USD Billion), 2021–2035 | |
  17. TABLE 3 Driver Impact Analysis | |
  18. TABLE 4 Restraints Impact Analysis | |
  19. TABLE 5 Regional Summary, by Region, 2025 | |
  20. TABLE 6 North America Market, by Country, 2025 | |
  21. TABLE 7 Europe Market, by Country, 2025 | |
  22. TABLE 8 Asia-Pacific Market, by Country, 2025 | |
  23. TABLE 9 South America Market, by Country, 2025 | |
  24. TABLE 10 Middle East & Africa Market, by Country, 2025 | |
  25. TABLE 11 Global Market, by Product Type, 2025–2035 | |
  26. TABLE 12 Global Market, by Application, 2025–2035 | |
  27. TABLE 13 Global Market, by End User, 2025–2035 | |
  28. TABLE 14 Competitive Benchmarking Matrix, 2025 | |
  29. TABLE 15 Report Scope and Methodology | |
  30. TABLE 16 Detailed Sources and Citations | | LIST OF FIGURES | |
  31. FIGURE 1 Market Dynamics Overview (Drivers, Restraints, Opportunities) | |
  32. FIGURE 2 Industry Value Chain Analysis | |
  33. FIGURE 3 Porter's Five Forces Analysis | |
  34. FIGURE 4 Global Market Size Trend (USD Billion), 2021–2035 | |
  35. FIGURE 5 Market Share, by Product Type, 2025 | |
  36. FIGURE 6 Market Share, by Application, 2025 | |
  37. FIGURE 7 Market Share, by End User, 2025 | |
  38. FIGURE 8 Regional Market Share, 2025 | |
  39. FIGURE 9 Country-Level Market Share, by Region, 2025 | |
  40. FIGURE 10 Competitive Landscape: Estimated Revenue Share Ranges, 2025

Segmentation Quick Reference

DimensionSub-SegmentsDominant SegmentFastest Growing Segment
By Product TypeNormal Balloons, Cutting Balloons, Scoring Balloons, Drug-Eluting BalloonsNormal Balloons (43.9% share)Scoring Balloons (4.6% CAGR)
By ApplicationCoronary Angioplasty, Peripheral AngioplastyCoronary Angioplasty (60.2% share)Peripheral Angioplasty (4.3% CAGR)
By End UserHospitals, Ambulatory Surgical Centers, OthersHospitals (75.6% share)Ambulatory Surgical Centers (4.9% CAGR)
By RegionNorth America, Europe, Asia-Pacific, South America, Middle East & AfricaNorth America (38.6% share)Asia-Pacific (5.1% CAGR)

Market Segmentation Overview

By Product Type

Sub-SegmentKey Trend
Normal BalloonsWorkhorse pre- and post-dilation tool under tender price pressure
Cutting BalloonsTargeted use in in-stent restenosis and small vessels
Scoring BalloonsFastest uptake as calcified lesion volumes rise
Drug-Eluting BalloonsU.S. coronary approval and sirolimus pipelines expand use

Normal Balloons lead with a 43.9% share because nearly every PCI uses one for pre-dilation or stent optimization. Scoring Balloons grow fastest at a 4.6% CAGR, since operators increasingly treat calcified vessels before stenting. Drug-Eluting Balloons add value per case but face stricter evidence requirements than uncoated designs.

By Application

Sub-SegmentKey Trend
Coronary AngioplastyHigh volume, growth capped by medical therapy
Peripheral AngioplastyRising PAD prevalence and below-the-knee innovation

Coronary Angioplasty leads with a 60.2% share, reflecting global PCI volume. Peripheral Angioplasty grows faster at a 4.3% CAGR because ageing and diabetes raise PAD prevalence, and the FDA's 2023 paclitaxel update restored confidence in coated balloons for leg arteries.

By End User

Sub-SegmentKey Trend
HospitalsRetain complex and emergency PCI
Ambulatory Surgical CentersMedicare reimbursement drives outpatient PCI
OthersOffice-based labs focused on peripheral work

Hospitals lead with a 75.6% share because acute and complex cases need full surgical backup. Ambulatory Surgical Centers grow fastest at a 4.9% CAGR, as CMS payment rules make low-risk outpatient PCI financially viable for physician-owned centers.

Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.